Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

10:45 AM - 12:00 PM ET

Emerging Data for Use of Radiotherapy in Nonmalignant Conditions
Speaker: Verhoeff, Joost, MD, PhD - UMC Utrecht, Utrecht, Utrecht
10:45 AM - 12:00 PM ET

Immunotherapy Integration and Immuno Biomarkers Across Mucosal and Cutaneous SCC
Speaker: Bratman, Scott, MD, PhD - Princess Margaret Cancer Centre, University of Toronto, Toronto, ON
10:45 AM - 12:00 PM ET

Immunotherapy Integration and Immuno Biomarkers Across Mucosal and Cutaneous SCC
Speaker: Young, Melissa, MD, PhD - Yale University, New Haven, CT
10:45 AM - 12:00 PM ET

Now is a STELLAR Time to TORCH Colorectal Cancer
Speaker: van Dams, Ritchell, MD, MHS - Mass General Brigham Cancer Institute, Boston, MA
10:45 AM - 12:00 PM ET

Now is a STELLAR Time to TORCH Colorectal Cancer
Speaker: Chakravarthy, A. Bapsi, MD, FASTRO - Vanderbilt University Medical Center, Nashville, TN
10:45 AM - 12:00 PM ET

Patient Reported Outcomes/QoL/Survivorship Oral Session
Speaker: Sio, Terence, MD, MS, FASTRO - Mayo Clinic, Phoenix, AZ
10:45 AM - 12:00 PM ET

Some crHEME with Your Coffee? A Winning Blend of Radiation and Systemic Therapy in Hematologic Malignancies
Speaker: Oertel, Michael, MD, PhD - University Hospital of Muenster, Muenster, Nordrhein-
10:45 AM - 12:00 PM ET

Some crHEME with Your Coffee? A Winning Blend of Radiation and Systemic Therapy in Hematologic Malignancies
Speaker: Wu, Susan, MD - MD Anderson Cancer Center, Houston, TX
10:55 AM - 11:05 AM ET

166 - FAPI-Guided Radiotherapy + Cadonilimab with Systemic Therapy vs. Systemic Therapy Alone in Second-Line Treatment of Colorectal Peritoneal Metastasis (TORCH-PM01)
Speaker: Zhang, Zhiyuan, MD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
10:55 AM - 11:05 AM ET

173 - C-Post Study of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma: Impact of Adjuvant Radiotherapy on Disease-Free Survival
Speaker: Adams, Gerard, MB, ChB, FRANZCR - Genesis Care Bundaberg, Bundaberg, QLD
10:55 AM - 11:05 AM ET

178 - A Dose Escalation Study of Papaverine As a Selective Hypoxic Radiosensitizer for Lung Stereotactic Body Radiation Therapy (SBRT) In the Treatment of Early-Stage Non-Small Cell Lung Cancer (NSCLC) and Other Malignancies
Speaker: Brownstein, Jeremy, MD, MS - Ohio State University James Cancer Hospital, Columbus, OH
10:55 AM - 11:05 AM ET

184 - A Randomized Controlled Trial of Dose Evaluation in Single-Fraction Electron Beam Radiotherapy for Keloids
Speaker: Lin, Ching-Chia, MD - Far Eastern Memorial Hospital, New Taipei City, New Taipei City